-+ 0.00%
-+ 0.00%
-+ 0.00%

Dyne Therapeutics director Brian S. Posner acquires $40,000 in common shares

PUBT·10/06/2026 20:15:47
Listen to the news
Dyne Therapeutics director Brian S. Posner acquires $40,000 in common shares
  • Dyne Therapeutics director Brian S. Posner bought 2,500 common shares at $16 per share.
  • Directly held stake rose to 27,000 shares following the purchase.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dyne Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-415584), on October 06, 2026, and is solely responsible for the information contained therein.